SCHEMBL10357571

SCHEMBL10357571

Oc1ccccc1-c1cc(-c2ccccc2Cl)[nH]n1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 14/20 1.00
KMT2A Q03164 14/20 1.00
ALOX15 P16050 12/20 1.00
MAPT P10636 10/20 1.00
HPGD P15428 10/20 1.00
SMN1; SMN2 Q16637 8/20 1.00
NFKB1 P19838 5/20 1.00
NFKB2 Q00653 5/20 1.00
RELA Q04206 5/20 1.00
ALOX12 P18054 3/20 1.00
HSD17B10 Q99714 2/20 1.00
RAB9A P51151 7/20 0.76
NPC1 O15118 6/20 0.76
ALDH1A1 P00352 4/20 0.76
TP53 P04637 4/20 0.76
USP2 O75604 3/20 0.76
TSHR P16473 1/20 0.68
KDM4E B2RXH2 3/20 0.58
LMNA P02545 4/20 0.55
MAPK1 P28482 4/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17938574 0.88 MEN1 (0.78) MEN1KMT2AALOX15MAPTHPGD
SCHEMBL403449 0.87 KMT2A (1.00) MEN1KMT2AALOX15MAPTHPGD
SCHEMBL10357394 0.86 MAPT (0.82) MEN1KMT2AALOX15MAPTHPGD
SCHEMBL22415570 0.86 MAPT (0.76) MEN1KMT2AALOX15MAPTHPGD
SCHEMBL10357372 0.83 MAPT (0.90) MEN1KMT2AALOX15MAPTHPGD
SCHEMBL10357437 0.82 KMT2A (1.00) MEN1KMT2AALOX15MAPTHPGD
SCHEMBL10357362 0.81 KMT2A (0.78) MEN1KMT2AALOX15MAPTHPGD
SCHEMBL10357589 0.81 SMN1; SMN2 (1.00) MEN1KMT2AALOX15MAPTHPGD
SCHEMBL16841251 0.81 MEN1 (0.74) MEN1KMT2AALOX15MAPTHPGD
SCHEMBL10358211 0.81 MAPT (0.68) MEN1KMT2AALOX15MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120184583-A1 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-07-19 US disclosed
US-20120184583-A1 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-07-19 US disclosed
US-20100144798-A1 Modulators of ATP-Binding Cassette Transporters VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-06-10 US disclosed
US-20100144798-A1 Modulators of ATP-Binding Cassette Transporters VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120184583-A1 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS CFTR, ABCB1, ABCC2 MEN1 4723/4885KMT2A 4334/4885ALOX15 3215/4885
US-20100144798-A1 Modulators of ATP-Binding Cassette Transporters CFTR, ABCB1, ABCC2 MEN1 4723/4885KMT2A 4334/4885ALOX15 3215/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.